2021-06-28 | Monte Rosa Therapeutics, Inc. GLUE | 10 percent owner | 1.05M 20.5778% | $19.00 | $19.95M | -7.95% | ||
2021-03-16 | Marker Therapeutics, Inc. MRKR | 10 percent owner | 5.71M 9.5207% | $1.75 | $10M | -4.3% | ||
2020-12-04 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 4.4M 7.578% | $0.62 | $2.74M | +22.37% | ||
2020-07-28 | Inozyme Pharma, Inc. INZY | 10 percent owner | 500,000 1.2168% | $8.00 | $4M | +19.03% | ||
2020-07-14 | Nkarta, Inc. NKTX | 10 percent owner | 1.33M 2.1488% | $18.00 | $24M | -11.28% | ||
2020-04-03 | Sale | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 1,128 0.0062% | $2.66 | $3,000 | +19.07% | |
2019-07-22 | Mirum Pharmaceuticals, Inc. MIRM | 10 percent owner | 900,000 5.3814% | $15.00 | $13.5M | +5.09% | ||
2019-05-09 | Trevi Therapeutics, Inc. TRVI | 10 percent owner | 5M 24.2282% | $7.00 | $35M | -42.9% | ||
2019-05-07 | Regulus Therapeutics Inc. RGLS | 10 percent owner | 1.14M 6.1239% | $1.08 | $1.23M | -40% | ||
2018-02-26 | Sale | ARCA biopharma, Inc. ABIO | director | 1.46M 11.9306% | $0.50 | $731,273 | +22.22% | |
2016-07-18 | Ardelyx, Inc. ARDX | 10 percent owner | 3.05M 5.9523% | $8.73 | $26.67M | +25.38% | ||
2016-01-13 | Ardelyx, Inc. ARDX | 10 percent owner | 1M 3.0335% | $10.00 | $10M | +4.47% |